COVID-19 Vaccine Performance: What’s Currently Known?

Slideshow

The US Centers for Disease Control and Prevention recently updated its science brief on COVID-19 vaccines currently authorized for emergency use (Pfizer-BioNTech, Moderna, and Johnson & Johnson), in which the agency synthesized the latest clinical trial data available through July 24, 2021. Data were added on vaccine efficacy and effectiveness against SARS-CoV-2 infection and SARS-CoV-2 variants, including the now dominant Delta variant. In the slides below, we summarize the key takeaways for primary care.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
© 2024 MJH Life Sciences

All rights reserved.